187 related articles for article (PubMed ID: 2380171)
1. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
[TBL] [Abstract][Full Text] [Related]
2. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
[TBL] [Abstract][Full Text] [Related]
4. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity.
Ye J; Liu LW; Esmon CT; Johnson AE
J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
Schmitz T; Rothe M; Dodt J
Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
[TBL] [Abstract][Full Text] [Related]
6. Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin.
Li CQ; Vindigni A; Sadler JE; Wardell MR
J Biol Chem; 2001 Mar; 276(9):6161-8. PubMed ID: 11024046
[TBL] [Abstract][Full Text] [Related]
7. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor.
Qiu X; Yin M; Padmanabhan KP; Krstenansky JL; Tulinsky A
J Biol Chem; 1993 Sep; 268(27):20318-26. PubMed ID: 8376390
[TBL] [Abstract][Full Text] [Related]
8. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
DiMaio J; Ni F; Gibbs B; Konishi Y
FEBS Lett; 1991 Apr; 282(1):47-52. PubMed ID: 2026264
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
Liu LW; Ye J; Johnson AE; Esmon CT
J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
Hortin GL; Tollefsen DM; Benutto BM
J Biol Chem; 1989 Aug; 264(24):13979-82. PubMed ID: 2760054
[TBL] [Abstract][Full Text] [Related]
11. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin.
Naski MC; Shafer JA
J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
Ofosu FA
Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
[TBL] [Abstract][Full Text] [Related]
13. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors.
Lombardi A; Nastri F; Della Morte R; Rossi A; De Rosa A; Staiano N; Pedone C; Pavone V
J Med Chem; 1996 May; 39(10):2008-17. PubMed ID: 8642559
[TBL] [Abstract][Full Text] [Related]
14. Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity.
Mao SJ; Yates MT; Owen TJ; Krstenansky JL
Biochemistry; 1988 Oct; 27(21):8170-3. PubMed ID: 3233202
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-bound conformation of the C-terminal fragments of hirudin determined by transferred nuclear Overhauser effects.
Ni F; Konishi Y; Scheraga HA
Biochemistry; 1990 May; 29(18):4479-89. PubMed ID: 2350549
[TBL] [Abstract][Full Text] [Related]
16. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin.
Maraganore JM; Bourdon P; Jablonski J; Ramachandran KL; Fenton JW
Biochemistry; 1990 Jul; 29(30):7095-101. PubMed ID: 2223763
[TBL] [Abstract][Full Text] [Related]
17. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant activity of synthetic hirudin peptides.
Maraganore JM; Chao B; Joseph ML; Jablonski J; Ramachandran KL
J Biol Chem; 1989 May; 264(15):8692-8. PubMed ID: 2722794
[TBL] [Abstract][Full Text] [Related]
19. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
Hortin GL; Trimpe BL
J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
[TBL] [Abstract][Full Text] [Related]
20. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
